The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
<p>Myelodysplastic Syndromes (MDS) are a heterogeneous group of haematological malignancies characterised by ineffective haematopoiesis and dysplastic bone marrow changes. Patients frequently progress to Acute Myeloid Leukaemia and this is associated with very poor clinical outcomes. This t...
Auteur principal: | Doolittle, H |
---|---|
Autres auteurs: | Jacobsen, S |
Format: | Thèse |
Publié: |
2017
|
Documents similaires
-
Characterising early human lympho-myeloid haematopoietic progenitors and their relationship with acute myeloid leukaemia stem cells
par: Aboukhalil, Z
Publié: (2018) -
TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
par: Pimjai Niparuck, et autres
Publié: (2021-10-01) -
TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
par: Ramy Rahmé, et autres
Publié: (2023-04-01) -
TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
par: Daver, NG, et autres
Publié: (2022) -
Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study
par: Yuxin Wang, et autres
Publié: (2022-07-01)